Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Prepaid Assets (2016 - 2025)

Ironwood Pharmaceuticals' Prepaid Assets history spans 16 years, with the latest figure at $12.0 million for Q4 2025.

  • For Q4 2025, Prepaid Assets changed 0.45% year-over-year to $12.0 million; the TTM value through Dec 2025 reached $12.0 million, changed 0.45%, while the annual FY2025 figure was $12.0 million, 0.45% changed from the prior year.
  • Prepaid Assets for Q4 2025 was $12.0 million at Ironwood Pharmaceuticals, down from $13.1 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $22.5 million in Q2 2023 and bottomed at $7.0 million in Q3 2022.
  • The 5-year median for Prepaid Assets is $12.0 million (2023), against an average of $12.1 million.
  • The largest annual shift saw Prepaid Assets soared 158.34% in 2023 before it tumbled 35.34% in 2024.
  • A 5-year view of Prepaid Assets shows it stood at $8.7 million in 2021, then fell by 11.21% to $7.7 million in 2022, then surged by 55.7% to $12.0 million in 2023, then fell by 0.74% to $11.9 million in 2024, then increased by 0.45% to $12.0 million in 2025.
  • Per Business Quant, the three most recent readings for IRWD's Prepaid Assets are $12.0 million (Q4 2025), $13.1 million (Q3 2025), and $12.7 million (Q2 2025).